This topic contains a solution. Click here to go to the answer

Author Question: When obtaining informed consent from study subjects, the researcher will ensure that subjects freely ... (Read 43 times)

jman1234

  • Hero Member
  • *****
  • Posts: 560
When obtaining informed consent from study subjects, the researcher will ensure that subjects freely choose whether or not to participate and will provide subjects
 
  a. general knowledge and overview of the study.
  b. information about the study methods and design.
  c. reports about the study results and conclusions.
  d. the right to choose whether to be in the control versus the study group.

Question 2

A special concern when conducting research using terminally ill cancer patients as subjects is
 
  a. an inability to randomly assign subjects to study groups.
  b. an increased risk of harm with decreased benefits.
  c. difficulty enlisting subjects for participation in the study.
  d. poor control of extraneous variables.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

marict

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

ANS: A

Answer to Question 2

ANS: B




jman1234

  • Member
  • Posts: 560
Reply 2 on: Jul 8, 2018
Gracias!


EAN94

  • Member
  • Posts: 307
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

For a complete list of videos, visit our video library